According to an article published on August 6 in a special HIV/AIDS issue of JAMA, a low-dose hormone treatment for human immunodeficiency virus (HIV)-infected patients who have treatment-related abdominal obesity and growth hormone deficiency resulted in gains in fat and blood pressure measurements. However, Steven Grinspoon, M.D. (Massachusetts General Hospital, Boston) and colleagues also found that the treatment worsened glucose levels.